Data as of 9:53am ET
| +0.03 / +1.76%|
The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 2.75, with a high estimate of 3.50 and a low estimate of 2.00. The median estimate represents a +58.96% increase from the last price of 1.73.
The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.